Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jul 1;131(1):83-94.
doi: 10.1152/japplphysiol.00634.2020. Epub 2021 May 20.

Postcontractile blood oxygenation level-dependent (BOLD) response in Duchenne muscular dystrophy

Affiliations

Postcontractile blood oxygenation level-dependent (BOLD) response in Duchenne muscular dystrophy

Christopher Lopez et al. J Appl Physiol (1985). .

Abstract

Duchenne muscular dystrophy (DMD) is characterized by a progressive replacement of muscle by fat and fibrous tissue, muscle weakness, and loss of functional abilities. Impaired vasodilatory and blood flow responses to muscle activation have also been observed in DMD and associated with mislocalization of neuronal nitric oxide synthase mu (nNOSμ) from the sarcolemma. The objective of this study was to determine whether the postcontractile blood oxygen level-dependent (BOLD) MRI response is impaired in DMD and correlated with established markers of disease severity in DMD, including MRI muscle fat fraction (FF) and clinical functional measures. Young boys with DMD (n = 16, 5-14 yr) and unaffected controls (n = 16, 5-14 yr) were evaluated using postcontractile BOLD, FF, and functional assessments. The BOLD response was measured following five brief (2 s) maximal voluntary dorsiflexion contractions, each separated by 1 min of rest. FFs from the anterior compartment lower leg muscles were quantified via chemical shift-encoded imaging. Functional abilities were assessed using the 10 m walk/run and the 6-min walk distance (6MWD). The peak BOLD responses in the tibialis anterior and extensor digitorum longus were reduced (P < 0.001) in DMD compared with controls. Furthermore, the anterior compartment peak BOLD response correlated with function (6MWD ρ = 0.87, P < 0.0001; 10 m walk/run time ρ = -0.78, P < 0.001) and FF (ρ = -0.52, P = 0.05). The reduced postcontractile BOLD response in DMD may reflect impaired microvascular function. The relationship observed between the postcontractile peak BOLD response and functional measures and FF suggests that the BOLD response is altered with disease severity in DMD.NEW & NOTEWORTHY This study examined the postcontractile blood oxygen level-dependent (BOLD) response in boys with Duchenne muscular dystrophy (DMD) and unaffected controls, and correlated this measure to markers of disease severity. Our findings indicate that the postcontractile BOLD response is impaired in DMD after brief muscle contractions, is correlated to disease severity, and may be valuable to implement in future studies to evaluate treatments targeting microvascular function in DMD.

Keywords: Duchenne muscular dystrophy; blood oxygenation level dependent; magnetic resonance imaging; microvascular; skeletal muscle.

PubMed Disclaimer

Conflict of interest statement

No conflicts of interest, financial or otherwise, are declared by the authors.

Figures

Figure 1.
Figure 1.
Representative high-resolution water Dixon image used for drawing of region of interest (ROI) for blood oxygen level-dependent analysis (BOLD), and corresponding echo planar image (image 1/360) acquired to measure dynamic BOLD response in a control (A) and a participant with Duchenne muscular dystrophy (DMD; B). EDL, extensor digitorum longus; TA, tibialis anterior.
Figure 2.
Figure 2.
Example force (control: A; DMD: B) and postcontractile blood oxygen level-dependent (BOLD) responses in a control and in a participant with Duchenne muscular dystrophy (DMD) of the tibialis anterior (control: C; DMD: D) and extensor digitorum longus (control: E; DMD: F). Five isometric maximal voluntary dorsiflexion contractions were performed separated by 1 min of rest.
Figure 3.
Figure 3.
Postcontractile BOLD responses of each contraction and the responses are averaged for an overall average BOLD response of the tibialis anterior (control: A; DMD: B) and extensor digitorum longus (control: C; DMD: D). Contraction artifacts were omitted from the BOLD analysis. The peak BOLD response, time to peak, and half-recovery time were evaluated after fitting the postcontractile BOLD response using a polynomial fitting algorithm. BOLD, blood oxygen level-dependent; DMD, Duchenne muscular dystrophy.
Figure 4.
Figure 4.
Parameters of the postcontractile blood oxygen level-dependent (BOLD) response were compared between unaffected controls (n = 15) and participants with Duchenne muscular dystrophy (DMD; n = 15), including the peak BOLD response (A), time to peak (B), and the half recovery time (C) for the tibialis anterior and the peak BOLD response (D), time to peak (E), and half recovery time (F) for the extensor digitorum longus. Welch’s unpaired two-tailed t test was used to compare DMD and unaffected controls. Box and whisker plots represent median, 10/90 percentile, and minimum/maximum. *P < 0.05, **P < 0.001.
Figure 5.
Figure 5.
A: correlation plot with initial (x-axis) and repeated (y-axis) of BOLD responses of the tibialis anterior muscle from both control (n = 4) and Duchenne muscular dystrophy (DMD; n = 7) subjects that repeated the BOLD protocol (ICC = 0.94). B: Bland–Altman plot showing limits of agreement (±1.96SD) and bias (0.21) of the (absolute) peak BOLD response. BOLD, blood oxygen level-dependent.
Figure 6.
Figure 6.
Correlation between the postcontractile peak BOLD response of the anterior compartment (weighted average of the tibialis anterior and extensor digitorum longus) vs. the 6-min walk distance (6MWD; ρ = 0.87, P < 0.0001, n = 15; A), 10-m walk/run time (ρ = −0.78, P < 0.001, n = 15; B), and fat fraction of the anterior compartment (ρ = −0.52, P = 0.05; C) in participants with DMD. Data were analyzed using Spearman’s correlation analyses. BOLD, blood oxygen level-dependent; DMD, Duchenne muscular dystrophy.

Similar articles

Cited by

References

    1. Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L, Kaul A, Kinnett K, McDonald C, Pandya S, Poysky J, Shapiro F, Tomezsko J, Constantin C; DMD Care Considerations Working Group. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol 9: 77–93, 2010. doi:10.1016/S1474-4422(09)70271-6. - DOI - PubMed
    1. Hoffman EP, Brown RH, Kunkel LM. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 51: 919–928, 1987. doi:10.1016/0092-8674(87)90579-4. - DOI - PubMed
    1. Adams ME, Odom GL, Kim MJ, Chamberlain JS, Froehner SC. Syntrophin binds directly to multiple spectrin-like repeats in dystrophin and mediates binding of nNOS to repeats 16-17. Hum Mol Genet 27: 2978–2985, 2018. doi:10.1093/hmg/ddy197. - DOI - PMC - PubMed
    1. Heydemann A, McNally E. NO more muscle fatigue. J Clin Invest 119: 448–450, 2009. doi:10.1172/jci38618. - DOI - PMC - PubMed
    1. Lai Y, Thomas GD, Yue Y, Yang HT, Li D, Long C, Judge L, Bostick B, Chamberlain JS, Terjung RL, Duan D. Dystrophins carrying spectrin-like repeats 16 and 17 anchor nNOS to the sarcolemma and enhance exercise performance in a mouse model of muscular dystrophy. J Clin Invest 119: 624–635, 2009. doi:10.1172/JCI36612. - DOI - PMC - PubMed

Publication types

LinkOut - more resources